Cyclopeptide analogs for generating new molecular and 3D diversity

Combinatorial Chemistry and High Throughput Screening

Volumn 12, Issue 10, 2009, Pages 929-939

  Gentilucci, Luca ^a   Cardillo, Giuliana ^a   Tolomelli, Alessandra ^a   Squassabia, Federico ^a   De Marco, Rossella ^a   Chiriano, Gianpaolo ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Cyclotetrapeptide; Peptide library; Retro inverso; Scaffold

Indexed keywords

CYCLOPEPTIDE; PEPTIDOMIMETIC AGENT;

ARTICLE; CHEMICAL MODIFICATION; CONTROLLED STUDY; CYCLIZATION; DEPROTECTION REACTION; DRUG CONFORMATION; DRUG DESIGN; DRUG SYNTHESIS; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN STRUCTURE; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ANALYSIS;

AMINO ACID SEQUENCE; MODELS, MOLECULAR; PEPTIDE LIBRARY; PEPTIDES, CYCLIC; PROTEIN CONFORMATION;

EID: 71249158761     PISSN: 13862073     EISSN: None     Source Type: Journal    
DOI: 10.2174/138620709789824754     Document Type: Article

References (45)

1. Gentilucci, L.; Tolomelli, A.; Squassabia, F. Peptides and peptidomimetics in medicine, surgery and biotechnology. Curr. Med. Chem., 2006, 13(20), 2449-2466.
2. Hruby, V.J. Conformational and topographical considerations in the design of biologically active peptides. Biopolymers, 1993, 33(7), 1073-1082. (Pubitemid 23184442)
3. Hruby, V.J.; Al-Obeidi, F.; Kazmierski, W. Emerging approaches in the molecular design of receptor-selective peptide ligands: conformational, topographical and dynamic considerations. Biochem. J., 1990, 268, 249-262. (Pubitemid 20193959)
4. Baran, I.; Svobodova Varekova, R.; Parthasarathi, L.; Suchomel, S.; Casey, F.; Shields, D.C.; Identification of potential small molecule peptidomimetics similar to motifs in proteins. J. Chem. Inf. Model., 2007, 47(2), 464-474.
5. Bleicher, K.H.; Boehm, H.-J.; Mueller, K.; Alanine, A.I. A guide to drug discovery: hit and lead generation: beyond high-throughput screening. Nat. Rev. Drug Discov., 2003, 2(5), 369-378.
6. Feher, M.; Schmidt, J.M. Property distributions: differences between drugs, natural products, and molecules from combinatorial chemistry. J. Chem. Inf. Comput. Sci., 2003, 43(1), 218-227.
7. Dobson, C.M. Chemical space and biology. Nature, 2004, 432(7019), 824-828.
8. Balaban, A.T. From chemical topology to 3D geometry. J. Chem. Inf. Comput. Sci., 1997, 37(4), 645-650.
9. Tyndall, J.D.A.; Pfeiffer, B.; Abbenante, G.; Fairlie, D.P. Over one hundred peptide-activated G protein-coupled receptors recognize ligands with turn structure. Chem. Rev., 2005, 105(3), 793-826.
10. Hruby, V.J.; Balse, P.M. Conformational and topographical considerations in designing agonist peptidomimetics from peptide leads. Curr. Med. Chem., 2000, 7(9), 945-970.
11. Carotenuto, A.; D'Ursi, A.M.; Mulinacci, B.; Paolini, I.; Lolli, F.; Papini, A.M.; Novellino, E.; Rovero, P. Conformation-activity relationship of designed glycopeptides as synthetic probes for the detection of autoantibodies, biomarkers of Multiple Sclerosis. J. Med. Chem., 2006, 49(17), 5072-5079. (Pubitemid 44260204)
12. Dings, R.P.M.; Mayo, K.H. A journey in structure-based drug discovery: from designed peptides to protein surface topomimetics as antibiotic and antiangiogenic agents. Acc. Chem. Res., 2007, 40(10), 1057-1065.
13. Murphy, P.V.; Dunne, J.L. Syntheses of peptidomimetics based on pyranose and polyhydroxylated piperidine scaffolds. Curr. Org. Synth., 2006, 3(4), 403-437.
14. Le, G.T.; Abbenante, G.; Becker, B.; Grathwohl, M.; Halliday, J.; Tometzki, G.; Zuegg, J.; Meutermans, W. Molecular diversity through sugar scaffolds. Drug Discov.Today, 2003, 8(15), 701-704. (Pubitemid 36970001)
15. Trabocchi, A.; Menchi, G.; Guarna, F.; Machetti, F.; Scarpi, D.; Guarna, A. Design, synthesis, and applications of 3-Aza-6, 8-Dioxabicyclo[3.2.1]Octane- based scaffolds for peptidomimetic chemistry. Synlett, 2006, 3, 331-353.
16. Souers, A.J.; Ellman, J.A. β-turn mimetic library synthesis: scaffolds and applications. Tetrahedron, 2001, 57(35), 7431-7448.
17. Loiseau, N.; Gomis, J.-M.; Santolini, J.; Delaforge, M.; Andre, F. Predicting the conformational states of cyclic tetrapeptides. Biopolymers, 2003, 69(3), 363-385. (Pubitemid 36841400)
18. Schumann, F.; Muller, A.; Koksch, M.; Muller, G.; Sewald, N. Are β-amino acids γ-turn mimetics? Exploring a new design principle for bioactive cyclopeptides. J. Am. Chem. Soc., 2000, 122(48), 12009-12010.
19. Glenn, M.P.; Kelso, M.J.; Tyndall, J.D.A.; Fairlie, D.P. Conformationally homogeneous cyclic tetrapeptides: useful new three-dimensional scaffolds. J. Am. Chem. Soc., 2003, 125(3), 640-641.
20. Mora, P.; Mas-Moruno, C.; Tamborero, S.; Cruz, L.J.; Perez-Paya, E.; Albericio, F. Design of a minimized cyclic tetrapeptide that neutralizes bacterial endotoxins. J. Pept. Sci., 2006, 12(7), 491-496. (Pubitemid 44057164)
21. Chorev, M.; Goodman, M. A dozen years of retro-inverso peptidomimetics. Acc. Chem. Res., 1993, 26(5), 266-273.
22. Fletcher, M.D.; Campbell, M.M. Partially modified retro-inverso peptides: development, synthesis, and conformational behavior. Chem. Rev., 1998, 98(2), 763-796.
23. Chorev, M. The partial retro-inverso modification: a road traveled together. Pept. Sci., 2005, 80(2-3), 67-84. (Pubitemid 40791045)
24. Lee, Y.S.; Agnes, R.S.; Davis, P.; Ma, S.-W.; Badghisi, H.; Lai, J.; Porreca, F.; Hruby, V.J. Partial retro-inverso, retro, and inverso modifications of hydrazide linked bifunctional peptides for opioid and cholecystokinin (CCK) receptors. J. Med. Chem., 2007, 50(1), 165-168.
25. Kim, K.-J.; Park, S.-W.; Yoon, S.S.J. Olefin epoxidation catalysis by peptidic Co(IIIcomplexes. Kor. Chem. Soc., 2000, 44(3), 286-289.
26. Han, Y.; Giragossian, C.; Mierke, D.F.; Chorev, M. Ni-to-Ni + 3-Ethylene-bridged partially modified retro-inverso tetrapeptide β-turn mimetic: design, synthesis, and structural characterization. J. Org. Chem., 2002, 67(15), 5085-5097. (Pubitemid 34793173)
27. Cornell, W.D.; Cieplak, P.; Bayly, C.I.; Gould, I.R.; Merz, K.M.; Ferguson, D.M.; Spellmeyer, D.C.; Fox, T.; Caldwell, J.W.; Kollman, P.A. A second generation force field for the simulation of proteins, nucleic acids, and organic molecules. J. Am. Chem. Soc., 1995, 117(19), 5179-5197.
28. Jorgensen, W.L.; Chandrasekhar, J.; Madura, J.; Impey, R.W.; Klein, M.L. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys., 1983, 79(2), 926-935.
29. Berendsen, H. J.C.; Postma, J.P.M.; van Gunsteren, W.F.; DiNola, A.; Haak, J.R. Molecular dynamics with coupling to an external bath. J. Chem. Phys., 1984, 81(8), 3684-3690.
30. Nakabayashi, S.; Warren, C.D.; Jeanloz, R.W. The preparation of a partially protected heptasaccharide-asparagine intermediate for glycopeptide synthesis. Carbohydr. Res., 1988, 174, 279-289.
31. Morie, T.; Kato, S.; Harada, H.; Fujiwara, I.; Watanabe, K.; Matsumoto, J.-I. Ring expansion of nitrogen-containing chloromethylheteroalicycles via aziridinium intermediates. J. Chem. Soc. Perkin Trans. 1. 1994, 18, 2565-2570.
32. Lucet, D.; Le Gall, T.; Mioskowski, C. The chemistry of vicinal diamines. Angew. Chem. Int. Ed. Engl., 1998, 37(19), 2580-12567
33. Pittelkow, M.; Lewinsky, R.; Christensen, J.B. Selective synthesis of carbamate protected polyamines using alkyl phenyl carbonates. Synthesis, 2002, 15, 2195-2202.
34. Felder, D.; Gutiérrez Nava, M.; del Pilar Carreón, M.; Eckert, J.-F.; Luccisano, M.; Schall, C.; Masson, P.; Gallani, J.-L.; Heinrich, B.; Guillon, D.; Nierengarten, J.-F. Synthesis of amphiphilic fullerene derivatives and their incorporation in Langmuir and Langmuir- Blodgett films. Helv. Chim. Acta., 2002, 85(1), 288-319.
35. Gentilucci, L.; Cardillo, G.; Tolomelli, A.; Spampinato, S.; Sparta, A.; Squassabia, F. Cyclotetrapeptide mimics based on a 13-membered, partially modified retro-inverso structure. Eur. J. Org. Chem., 2008, 729-735.
36. Gentilucci, L.; Tolomelli, A. Recent advances in the investigation of the bioactive conformation of peptides active at the m-opioid receptor. Conformational analysis of endomorphins. Curr. Top. Med. Chem., 2004, 4(1), 105-121. (Pubitemid 38842562)
37. Stradley, S.J.; Rizo, J.; Bruch, M.D.; Stroup, A.N.; Gierasch, L.M. Cyclic pentapeptides as models for reverse turns: Determination of the equilibrium distribution between type I and type II conformations of Pro-Asn and Pro-Ala b-turns. Biopolymers, 1990, 29(1), 263-287.
38. Kessler, H. Conformation and biological activity of cyclic peptides. Angew. Chem. Int. Ed. Engl., 1982, 21(7), 512-523.
39. Toniolo, C. Intramolecularly hydrogen-bonded peptide conformations. CRC Crit. Rev. Biochem., 1980, 9(1), 1-44.
40. Cardillo, G.; Gentilucci, L.; Tolomelli, A.; Spinosa, R.; Calienni, M.; Qasem, A.R.; Spampinato, S. Synthesis and evaluation of the affinity toward μioid receptors of atypical, lipophilic ligands based on the sequence c[-Tyr-Pro-Trp-Phe-Gly-]. J. Med. Chem., 2004, 47(21), 5198-5203. (Pubitemid 39314916)
41. Gentilucci, L.; Squassabia, F.; Artali, R. Re-discussion of the importance of ionic interactions in stabilizing ligand-opioid receptor complex and in activating signal transduction. Curr. Drug Targets, 2007, 8(1), 185-196. (Pubitemid 46043907)
42. 2-amino acids in the design of conformationally homogeneous cyclo-peptide scaffolds. J. Org. Chem., 2006, 71(18), 6814-6821.
43. Maulucci, N.; Chini, M.G.; Di Micco, S.; Izzo, I.; Cafaro, E.; Russo, A.; Gallinari, P.; Paolini, C.; Nardi, M.C.; Casapullo, A.; Riccio, R.; Bifulco, G.; De Riccardis, F. Molecular insights into azumamide e histone deacetylases inhibitory activity. J. Am. Chem. Soc., 2007, 129(10), 3007-3012. (Pubitemid 46417978)
44. Henry, C.; Moitessier, N.; Chapleur, Y. Vitronectin receptor -avb3 integrin- antagonists: chemical and structural requirements for activity and selectivity. Mini. Rev. Med. Chem., 2002, 2(6), 531-542.
45. 3 antagonists. J. Am. Chem. Soc., 1996, 118(32), 7461-7462.